
Box Deutschland8














Now we know the challenges, how do current systems used in many #lifesciences organizations deliver for the users? Which areas are lacking? https://www.crowdchat.net/s/15qco

Suhela Dighe
Oh wow, very few say their current systems are performing very well...

Alexander Schweigart
What strikes me here are the difficulties to access (the right) information and to have it available during the complete process.

Suhela Dighe
Quite shocking really. I guess, with the information needs and volume changing so fast, older systems can't keep up??

Alexander Schweigart
Historically most organizations established (at least) two major repositories: One for regulated and one for non-regulated content. But as content can become GxP-relevant at one point in time of its' lifecycle, a copy is made to an other system - which causes confusion over time

Alexander Schweigart
Also the integrations in other systems holds major room for improvement. In times where best-of-breed solutions can be easily adopted even by smaller teams within the organization, it is critical to avoid that every one of these is creating a new content silo of its' own.

Dale Vile
I think the main issue is that when systems are limited, things still get done, but more not very efficiently, and with a high degree of cost, risk and distraction.

Alexander Schweigart
Providing one foundation for ALL content types, effortless permission controls and embedded collaboration features can takle a wide portion of these issues.

Box Deutschland
How bad is the #collaboration gap? What does it mean for specific teams (#Research #clinicaltrials)?

Dale Vile
This impacts the individual, internal team collaboration, and collaboration between teams (including external)

Alexander Schweigart
Looking at the pink and yellow bars, I would say that there is a big opportunity for many #lifesciences organizations to improve in a way that really benefits the workforce.

Alexander Schweigart
If we look at the clinical domain as an example: If a sponsor company is conducting a Site Selection and Site Feasibility Analysis for a large Phase-III test, often times hundreds of CROs need to be evaluated and sensitive information has to be disclosed.

Alexander Schweigart
For many companies, this is still a very manual process that can "entertain" a dozen people in the ClinOps team for weeks. As most information is captured manually and needs to be transferred to other, not integrated systems, errors occur.

Dale Vile
On a specific point, I really don't think we should underestimate the implications of poor workflow.

Alexander Schweigart
Providing a solution that helps the internal staff to identify the right set of information quickly, securely share it with all CROs simultaneously, keep track of the progress and integrate the provided responses directly the system used for decision making can free-up value

Alexander Schweigart
expert time, cut the required time dramatically and increase the overall data quality.






